Conference Coverage

Conference News Roundup—European Stroke Organization


 

Simple Scan Still Effective in Deciding Stroke Treatment

A study led by a neurologist from McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) showed that a CT scan could be sufficient for determining thrombectomy treatment in stroke.

Thrombectomy has been shown to be an effective treatment for improving clinical outcomes in stroke up to 24 hours from onset. Stroke is the leading cause of long-term disability and the fourth leading cause of death globally. Imaging must be done to determine the location of the clot and whether the patient is a good candidate for thrombectomy. Physicians use noncontrast simple CT or CT perfusion to see the area.

“The results show that simple imaging, while not perfect, may be good enough. This basic technique is faster, which means patients could potentially be treated more quickly,” said Amrou Sarraj, MD, Associate Professor of Neurology at McGovern Medical School at UTHealth. “The advanced imaging of CT perfusion is not available everywhere, so this could open up the door to identify more people for potential treatment, especially in remote areas.”

Dr. Sarraj was the principal investigator of the study, Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT). The clinical trial enrolled 445 patients who received both simple and advanced imaging at nine academic health centers across the US from January 2016 to February 2018.

The results showed that patients who were treated based on simple imaging had identical clinical outcomes to those treated based on advanced imaging. In addition, those patients who had a good imaging profile (ie, a smaller area of dead brain tissue) had the same clinical outcomes, regardless of which imaging was used.

“If those treated using simple imaging can do as well as those treated by CT perfusion, this is an extremely important breakthrough that warrants further exploration and testing because it could broaden the number of patients having and benefiting from thrombectomy,” said Dr. Sarraj, who is also director of UTHealth’s vascular neurology fellowship program and an attending physician at Memorial Hermann-Texas Medical Center.

The study also revealed that 42% of patients who were excluded from thrombectomy by one of the imaging profiles, but had a good profile on the other type of imaging, had positive clinical outcomes.

“Our results should not be interpreted [to indicate] that advanced perfusion images are not necessary or should not be acquired at all, as they still identified a group of patients that may be treated with thrombectomy when CT alone was not enough. The numbers involved are significant because 17.6% of patients could have been excluded from having surgery if the CT or CT perfusion were relied on alone, so there is a real opportunity here to help more people if both forms of imaging are available,” Dr. Sarraj said.

The study did not randomize patient selection by simple imaging versus advanced imaging. “Although this was the first large cohort study with prespecified imaging criteria, analyses, and objectives to look at imaging type selection, there is room for further refinement to truly test our initial findings and see if they are more affirmative and conclusive,” Dr. Sarraj said.

Next Article: